Le Lézard
Classified in: Health, Business
Subjects: TNM, BCY

Elements Behavioral Health to Enter Into Purchase Agreement; Transaction Facilitated Through Chapter 11; Programs Continue and Treatment Centers Remain Open


LONG BEACH, Calif., May 23, 2018 /PRNewswire/ -- Elements Behavioral Health (the "Company"), a family of behavioral health programs located throughout the United States, announced today that it will execute an asset purchase agreement  (the "Purchase Agreement") with a group of its First Lien Lenders ("Lenders"). To facilitate the sale, the Company has initiated proceedings under chapter 11 of the United States Bankruptcy Code in the District of Delaware ("Court").

All Elements Behavioral Health programs continue to provide its innovative and comprehensive programs and patient services.

"Our commitment to bringing life-changing treatments to our patients and their families is unwavering and we hope that through this process we can leverage new resources and build a strong financial foundation, so that we can continue to help people reclaim their lives from addiction and mental health issues," said Dr. David Sack, Chief Medical Officer and Interim Chief Executive Officer of Elements Behavioral Health. "Treatment centers remain open and the company will continue to serve existing and new patients. As we move forward with our restructuring, we expect operations to continue as normal across our facilities, and we are committed to supporting our employees and maintaining our relationships with our business partners and vendors. We look forward to better positioning the Company for long-term success and profitability."

Business will continue uninterrupted, and operations will be supported by debtor-in-possession (DIP) financing provided by the Company's Lenders. The Company anticipates the transaction will move swiftly with the sale approval occurring within 4-6 weeks of the bankruptcy filing and closing to occur thereafter, subject to certain regulatory approvals.

Court filings as well as other information related to the Elements Behavioral Health chapter 11 sale are available at www.donlinrecano.com/ebh or by calling information center toll free at 1-866-416-0554, or international toll at 1-212-771-1128, or submit an inquiry via e-mail to [email protected].

The Company is represented by its legal advisor Polsinelli PC and its financial advisor Alvarez & Marsal. 

About Elements Behavioral Health

Elements Behavioral Health is a family of behavioral health programs located throughout the United States. The Elements Behavioral Health® family of programs offers comprehensive, innovative treatment for substance abuse, sexual addiction, trauma, eating disorders, and other mental health disorders. Through its programs, the company is committed to delivering clinically sophisticated treatment that promotes permanent lifestyle change, not only for the patient but for the entire family network. For more information, visit elementsbehavioralhealth.com.

Media Contact:  
Jennifer E. Mercer 
Donlin Recano Strategic Communications for Elements Behavioral Health 
818-802-5199 
[email protected]

SOURCE Elements Behavioral Health


These press releases may also interest you

10 mai 2024
On May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of Science, published a research paper titled "Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system...

10 mai 2024
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

10 mai 2024
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

10 mai 2024
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

10 mai 2024
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

10 mai 2024
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...



News published on and distributed by: